Biomarin Pharmaceutical Inc (LTS:0HNC)
$ 76.52 -1.36 (-1.75%) Market Cap: 14.63 Bil Enterprise Value: 14.68 Bil PE Ratio: 72.01 PB Ratio: 2.88 GF Score: 71/100

Biomarin Pharmaceutical Inc (LTS:0HNC) Transcripts

  • 1